Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
35
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
13 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Siemens Energy
AN
AnalystConsensusTarget
Consensus Narrative from 22 Analysts
Grid Modernization And Energy Transition Will Yield Mixed Results
Key Takeaways Overly optimistic expectations for rapid grid modernization, wind business turnaround, and international growth may not account for execution, policy, and affordability risks. Strong current order intake could mask future margin pressures, working capital strains, and potential revenue volatility from supply chain and market headwinds.
View narrative
€90.88
FV
2.2% overvalued
intrinsic discount
9.53%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
69
users have followed this narrative
Updated
narrative
Xencor
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
IBD Biologics And TL1A Programs Will Forge New Paths
Key Takeaways Differentiated drug design and flexible development platform position Xencor for increased patient adoption, operational efficiency, and attractive long-term profitability. Strong clinical strategy and alignment with healthcare trends support sustained market expansion and robust future revenue growth.
View narrative
US$25.20
FV
66.6% undervalued
intrinsic discount
7.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Brambles
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Investments In AI And Digital Solutions Will Improve Customer Experience And Efficiency
Key Takeaways Asset efficiency and strategic capital allocation drive better cash flow, net margins, and potential future earnings growth. Innovations in AI and digital solutions enhance customer experience and operational efficiency, supporting revenue growth and improved margins.
View narrative
AU$24.85
FV
6.0% overvalued
intrinsic discount
4.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
VIK
Viking Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Sustainable Fleet Expansion And New Markets Will Shape Future Success
Key Takeaways Expanding fleet, innovative vessels, and new geographic markets drive long-term growth, operational efficiency, and revenue diversification. Direct-to-consumer strategy and strong customer loyalty support premium pricing, high occupancy, and industry-leading margins.
View narrative
US$64.88
FV
6.9% undervalued
intrinsic discount
14.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
Updated
narrative
Costain Group
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
GBP 54 Billion In Secured Contracts Will Ensure Future Stability
Key Takeaways A robust secured work pipeline indicates a stable, long-term revenue stream, bolstering confidence in growth and profitability. Strategic focus on expanding markets and key contracts in various sectors drives anticipated revenue and profit increases by 2027.
View narrative
UK£1.82
FV
28.0% undervalued
intrinsic discount
8.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
Alliance Entertainment Holding
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Paramount Licensing And Collectibles Will Fuel Future Markets
Key Takeaways Exclusive licensing deals and demand for physical collectibles are strengthening revenue growth and competitive positioning, especially as new releases roll out. Automation, e-commerce expansion, and disciplined acquisitions are improving margins, diversifying revenue streams, and reducing operational risk.
View narrative
US$10.00
FV
48.0% undervalued
intrinsic discount
0.86%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
Updated
narrative
Adaptimmune Therapeutics
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
TCELRA And Lete-Cel Rollout Will Create Operational Efficiencies
Key Takeaways Rapid treatment network expansion and successful TECELRA launch are driving significant future revenue growth and patient access. Strategic cost reductions and successful manufacturing are enhancing net margins and paving the way towards long-term profitability.
View narrative
US$0.64
FV
91.1% undervalued
intrinsic discount
40.75%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
Updated
narrative
Astera Labs
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
UALink And PCIe Advancements Will Accelerate AI Infrastructure Deployment
Key Takeaways Diversified product adoption and strong industry partnerships are driving stable, long-term revenue growth and reducing customer concentration risk. Focus on open standards and comprehensive platform solutions positions Astera Labs to benefit from infrastructure shifts and higher margins in evolving AI data center markets.
View narrative
US$166.47
FV
7.6% overvalued
intrinsic discount
34.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
74
users have followed this narrative
Updated
narrative
Transocean
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Rising Regulatory Costs And High Debt Will Undermine Offshore Profitability
Key Takeaways Accelerating renewables adoption and regulatory pressure threaten long-term demand, margins, and revenue growth for Transocean's offshore drilling business. High debt, aging fleet, and increasing competition constrain financial flexibility and may significantly impact future profitability.
View narrative
US$2.50
FV
21.6% overvalued
intrinsic discount
-1.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies